MOBILion Systems delivers high-resolution, high-throughput analysis for the pharmaceutical industry and clinical researchers to enable earlier disease detection, improve diagnostic accuracy and to accelerate drug development with deeper, faster characterization of more complex biologic therapeutics.
| Date | Amount | Type | Investors | Valuation |
|---|---|---|---|---|
| 07/15/21 | $60,000,000 | Series C |
Agilent Technologies aMoon Cultivation Capital D1 Capital Partners  Hostplus IP Group | undisclosed |
